| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/18/1997 | WO1997033901A1 Smooth muscle cell lim protein |
| 09/18/1997 | WO1997033623A1 OLIGONUCLEOTIDES TARGETED TO ANGIOTENSINOGEN mRNA |
| 09/18/1997 | WO1997033608A2 Antagonism of endothelin actions |
| 09/18/1997 | WO1997033602A1 Peptides with increased binding affinity for hla molecules |
| 09/18/1997 | WO1997033474A1 Targeted site specific drug delivery compositions and method of use |
| 09/18/1997 | WO1997025067A3 Polymers |
| 09/18/1997 | WO1997023607A3 Presentation of antigen, introduced into cells by stimulation of macropinocytosis |
| 09/18/1997 | WO1997022695A3 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 09/18/1997 | CA2248978A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 09/18/1997 | CA2248932A1 Oligonucleotides targeted to angiotensinogen mrna |
| 09/18/1997 | CA2248927A1 Smooth muscle cell lim protein |
| 09/18/1997 | CA2248684A1 Immunity to trypanosomatids species |
| 09/18/1997 | CA2248657A1 Peptides with increased binding affinity for hla molecules |
| 09/18/1997 | CA2248612A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 09/18/1997 | CA2248549A1 Extracellular matrix signalling molecules |
| 09/18/1997 | CA2248538A1 Targeted delivery of genes encoding interferon |
| 09/18/1997 | CA2248355A1 Human membrane antigen tm4 superfamily protein and dna encoding this protein |
| 09/18/1997 | CA2248158A1 Targeted site specific drug delivery compositions and method of use |
| 09/18/1997 | CA2247804A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | CA2225913A1 Persephin and related growth factors |
| 09/17/1997 | EP0795325A1 Plasmid entrapping multilamellar liposomes |
| 09/17/1997 | EP0795021A2 Retroviral delivery of full length factor viii |
| 09/17/1997 | EP0795015A1 Plasmids suitable for il-2 expression |
| 09/17/1997 | EP0795014A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 09/17/1997 | EP0795007A1 Bioengineered human blood cells |
| 09/17/1997 | EP0795006A1 HUMAN MutT2 |
| 09/17/1997 | EP0794798A2 Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy |
| 09/17/1997 | EP0794797A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 09/17/1997 | CN1159829A 17q-linked breast and ovarian cancer susceptibility gene |
| 09/17/1997 | CN1159811A Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 09/16/1997 | US5668012 Platelet endothelial cell adhesion molecule-1 promoters and uses thereof |
| 09/16/1997 | US5667981 Diagnostics and treatments for cancers expressing tyrosine phosphorylated CRKL protein |
| 09/16/1997 | US5667969 Alteration of sequence of a deleterious target molecule by ribozyme catalyzed trans-splicing |
| 09/16/1997 | US5667777 Gene therapy for treatment of glomerular kidney disease, expression of beta-galactosidase |
| 09/16/1997 | US5667491 Method for rapid temporal control of molecular transport across tissue |
| 09/15/1997 | CA2200012A1 Plasmid entrapping multilamellar liposomes |
| 09/12/1997 | WO1997032993A1 Chemotactic cytokine iii |
| 09/12/1997 | WO1997032992A1 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, and in vitro generation of dendritic cells and macrophages |
| 09/12/1997 | WO1997032991A2 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors |
| 09/12/1997 | WO1997032989A2 Recombinant aav vector-based transduction system and use of same |
| 09/12/1997 | WO1997032988A1 Adeno-associated virus vector for boosting immunogenicity of cells |
| 09/12/1997 | WO1997032987A1 Methods and nucleic immunogenic compositions encoding antigens and co-stimulatory molecules for immunization |
| 09/12/1997 | WO1997032982A1 Human adhesion molecule occludin |
| 09/12/1997 | WO1997032979A1 Inhibition of proliferation of cells |
| 09/12/1997 | WO1997032887A1 Oligonucleotide analogues |
| 09/12/1997 | WO1997032608A1 Genetically engineered primary oligodendrocytes for transplantation-mediated gene delivery in the central nervous system |
| 09/12/1997 | WO1997032603A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| 09/12/1997 | WO1997032595A1 Method for treatment of insulin resistance |
| 09/12/1997 | WO1997032572A2 Materials and methods for enhancing cellular internalization |
| 09/12/1997 | WO1997023598A3 A long qt syndrome gene which encodes kvlqt1 and its association with mink |
| 09/12/1997 | WO1997021826A3 Complementary adenoviral vector systems and cell lines |
| 09/12/1997 | WO1997008199A3 Antimicrobial cationic peptides and methods of screening for the same |
| 09/12/1997 | WO1997004097A3 Human CTLA-8 and uses of CTLA-8-related proteins |
| 09/12/1997 | CA2248555A1 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, and in vitro generation of dendritic cells and macrophages |
| 09/12/1997 | CA2248350A1 Inhibition of proliferation of cells |
| 09/12/1997 | CA2247912A1 Genetically engineered primary oligodendrocytes for transplantation-mediated gene delivery in the central nervous system |
| 09/12/1997 | CA2247806A1 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors |
| 09/12/1997 | CA2247480A1 Oligonucleotide analogues |
| 09/12/1997 | CA2246333A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| 09/11/1997 | DE19608751A1 Adeno-assoziierter Virus-Vektor zur Steigerung der Immunogenität von Zellen Adeno-associated virus vector for enhancing the immunogenicity of cells |
| 09/10/1997 | EP0793725A1 Nuclear protein serine/threonine kinases |
| 09/10/1997 | EP0793722A2 Modified proteinase inhibitors |
| 09/10/1997 | EP0793721A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
| 09/10/1997 | EP0793719A2 Rna component of telomerase |
| 09/10/1997 | EP0793509A1 Viral vector complexes having adapters of predefined valence |
| 09/10/1997 | EP0793508A1 Novel nucleic acid molecules comprising the prostate specific antigen (psa) promoter and uses thereof |
| 09/10/1997 | EP0722330A4 Methods for analysis of human stem cells |
| 09/10/1997 | EP0699073A4 Allogeneic and xenogeneic transplantation |
| 09/10/1997 | CN1159210A Non self-inactivating, Expression targeted retroviral vectors |
| 09/10/1997 | CN1158856A Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide |
| 09/09/1997 | US5665873 Inhibits reactivation of herpes virus |
| 09/09/1997 | US5665593 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 09/09/1997 | US5665583 Methods and materials relating to IMPDH and GMP production |
| 09/09/1997 | US5665580 Antisense oligonucleotide inhibition of papillomavirus transformed cells |
| 09/09/1997 | US5665543 Method of discovering chemicals capable of functioning as gene expression modulators |
| 09/09/1997 | US5665380 Lipid vesicle fusion as a method of transmitting a biologically active material to a cell |
| 09/09/1997 | US5665350 Bone marrow stem cell engraftment |
| 09/04/1997 | WO1997032029A1 Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 09/04/1997 | WO1997032026A1 Adapter molecules for targeting viral particles to cells |
| 09/04/1997 | WO1997032025A1 Method for selective engraftment of drug-resistant hematopoietic stem cells |
| 09/04/1997 | WO1997032024A1 Allele suppression |
| 09/04/1997 | WO1997032021A1 Therapeutic agents based on monoclonal anti-idiotypic antibody 105ad7 |
| 09/04/1997 | WO1997032019A2 C-c ckr-5, cc-chemikines receptor, derivatives thereof and their uses |
| 09/04/1997 | WO1997032018A2 Hepatitis c virus ribozymes |
| 09/04/1997 | WO1997031927A1 Tetraether lipids and liposomes containing said lipids, and use of the same |
| 09/04/1997 | WO1997031656A1 Composition for stably introducing genes into liver cells and method of introducing genes by using said composition |
| 09/04/1997 | WO1997031642A1 Anti-hiv agent |
| 09/04/1997 | WO1997022699A3 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
| 09/04/1997 | WO1997016457A3 Anti-tumoral protein |
| 09/04/1997 | DE19607722A1 Tetraetherlipide und diese enthaltende Liposomen sowie deren Verwendung Tetraether and these liposomes containing them and their use |
| 09/03/1997 | EP0792931A2 Products and methods for controlling the suppression of the neoplastic phenotype |
| 09/03/1997 | EP0792370A1 INTERLEUKIN-1 $g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4 |
| 09/03/1997 | EP0792369A1 Suicide genes and combinations of pyrimidine nucleoside and nucleobase analogues with suicide genes for gene therapy |
| 09/03/1997 | EP0792366A1 Enzyme gene therapy catalysing prodrug extracellular conversion |
| 09/03/1997 | EP0792364A2 Lgmd gene coding for a calcium dependent protease |
| 09/03/1997 | EP0792359A1 Transcription factor e2f-4 |
| 09/03/1997 | EP0792358A2 A polynucleotide tuberculosis vaccine |
| 09/03/1997 | EP0792354A1 Targeted t lymphocytes |
| 09/03/1997 | EP0792350A1 Regulation of neural stem cell proliferation |
| 09/03/1997 | EP0792349A1 In vitro induction of dopaminergic cells |